Literature DB >> 7689171

Brief report: treatment with azacitidine of patients with end-stage beta-thalassemia.

C H Lowrey1, A W Nienhuis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7689171     DOI： 10.1056/NEJM199309163291205

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  27 in total

1.  siDNMT1 increases γ-globin expression in chemical inducer of dimerization (CID)-dependent mouse βYAC bone marrow cells and in baboon erythroid progenitor cell cultures.

Authors:  Virryan Banzon; Vinzon Ibanez; Kestis Vaitkus; Maria Armila Ruiz; Kenneth Peterson; Joseph DeSimone; Donald Lavelle
Journal:  Exp Hematol       Date:  2010-10-23       Impact factor: 3.084

2.  Developmental- and differentiation-specific patterns of human gamma- and beta-globin promoter DNA methylation.

Authors:  Rodwell Mabaera; Christine A Richardson; Kristin Johnson; Mei Hsu; Steven Fiering; Christopher H Lowrey
Journal:  Blood       Date:  2007-04-24       Impact factor: 22.113

Review 3.  Fetal Hemoglobin Induction by Epigenetic Drugs.

Authors:  Donald Lavelle; James Douglas Engel; Yogen Saunthararajah
Journal:  Semin Hematol       Date:  2018-04-22       Impact factor: 3.851

4.  Fetal globin induction--can it cure beta thalassemia?

Authors:  Susan P Perrine
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2005

5.  Induction of fetal hemoglobin through enhanced translation efficiency of γ-globin mRNA.

Authors:  Cynthia K Hahn; Christopher H Lowrey
Journal:  Blood       Date:  2014-08-28       Impact factor: 22.113

6.  Induction of Epstein-Barr virus kinases to sensitize tumor cells to nucleoside analogues.

Authors:  S M Moore; J S Cannon; Y C Tanhehco; F M Hamzeh; R F Ambinder
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

7.  Enhancement of growth and survival and alterations in Bcl-family proteins in beta-thalassemic erythroid progenitors by novel short-chain fatty acid derivatives.

Authors:  Serguei Castaneda; Michael S Boosalis; David Emery; Allison Thies; Douglas V Faller; Susan P Perrine
Journal:  Blood Cells Mol Dis       Date:  2005 Sep-Oct       Impact factor: 3.039

Review 8.  DNA methylation as a therapeutic target in hematologic disorders: recent results in older patients with myelodysplasia and acute myeloid leukemia.

Authors:  Björn Rüter; Pierre W Wijermans; Michael Lübbert
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

9.  Simvastatin and t-butylhydroquinone suppress KLF1 and BCL11A gene expression and additively increase fetal hemoglobin in primary human erythroid cells.

Authors:  Elizabeth R Macari; Emily K Schaeffer; Rachel J West; Christopher H Lowrey
Journal:  Blood       Date:  2012-12-06       Impact factor: 22.113

10.  A randomized phase I/II trial of HQK-1001, an oral fetal globin gene inducer, in β-thalassaemia intermedia and HbE/β-thalassaemia.

Authors:  Suthat Fucharoen; Adlette Inati; Noppadol Siritanaratku; Swee L Thein; William C Wargin; Suzanne Koussa; Ali Taher; Nattawara Chaneim; Michael Boosalis; Ronald Berenson; Susan P Perrine
Journal:  Br J Haematol       Date:  2013-03-27       Impact factor: 6.998
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.